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SYSTEMIC AND TOPICAL FACTORS INVOLVED IN THE PRODUCTION
OF EXPERIMENTAL CUTANEOUS CALCINOSIS*
HANS SELYE, M.D., Pn.D., D.Sc., SR. ADRIAN MARIE, O.P., Pu.D.t AND PIERRE JEAN, M.D.t
Extensive investigations dating back to 1932
(1, 2, 3) have shown that, in experimental ani-
mals, it is possible to produce cutaneous calcinosis
reminiscent of calcifying scieroderma (the
"sclérodermie calcaire" of French dermatologists)
with certain calcification-promoting compounds,
such as parathyroid hormone or dihydrotachy-
sterol (DHT). However, irrespective of the
evocative agent, the cutaneous lesions could not
serve as practical models of disease, because they
developed only on the scalp and neck (not
wherever the experimenter wanted to induce
them), occurred irregularly, were exclusive to
very young animals, and the accompanying
mortality was high. Still, these observations were
repeatedly confirmed by others and eventually
induced Leriche and co-workers (4, 5, 6) to re-
move the parathyroids in patients with severe
scieroderma. The results of this operation were
rather inconstant, but in some cases marked
improvement did occur, so that further work
designed to improve our experimental model was
thought to be desirable.
In the course of the following years, it was
found that topical trauma can cause local cal-
cification in the internal organs of DHT-treated
rats (7). Since clinical scleroderma also tends to
develop at sites of local injury (2), we were
particularly interested to note that cutaneous
calcinosis with sclerosis can be produced at will
in predetermined skin regions, even in adult rats,
if the selected area is lightly traumatized (e.g.,
by epilation) at a "critical time" of DHT treat-
ment, usually the 4th day (5).
Using this technic, the histogenesis of the
cutaneous calcinosis induced by DHT + topical
trauma was studied in detail (9), particularly in
order to clarify the similarities and dissimilarities
between this experimental condition and the
clinical syndrome of calcifying scleroderma. While
it remains questionable whether these two condi-
Received for publication August 2, 1960.
* From the Institut de Médecine et de Chirurgie
expérimentales, IJniversité de Montréal, Montreal,
Canada.
f Fellow of the Southern Fellowships Fund.
t Fellow of the Quebec Heart Foundation, Inc.
7
tions are identical or even fundamentally related,
there can be no doubt that the experimental dis-
ease closely resembles clinical cutaneous caleinosis
and, therefore, can serve as a practical laboratory
model of the latter.
A great deal of work is currently under way to
determine the factors able to promote or prevent
experimental cutaneous calcinosis; it has already
been possible to demonstrate that the condition
can be suppressed by suitable treatment, at the
"critical period" of its development, with the
lathyrogenic substance aminoacetonitrile, or
"AAN" (10). Preliminary experiments suggested
that the oral administration of certain electrolytes
known to enhance soft-tissue calcification (e.g.,
phosphates, calcium salts) greatly sensitizes the
DHT-treated rat for the production of cutaneous
calcification by the topical trauma of epilation.
It was found, furthermore, that in such experi-
ments the intracutaneous or subcutaneous in-
jection of small amounts of ferric chloride is
considerably more effective than epilation in
causing a topical predisposition for calcium depo-
sition.
The data reported in this communication indi-
cate that vitamin D2, an essential food ingre-
dient chemically related to DHT, can also
predispose to the production of cutaneous calcin-
osis and that its effect is considerably augmented
by the oral administration of sodium phosphate
or calcium acetate. It will be shown, furthermore,
that although normally neither vitamin D2 nor
FeCl3 produces topical calcification at the site of
injection, FeCl3 is highly effective in eliciting
local calcium deposition in the skin and sub-
cutaneous tissues of animals sensitized by oral
vitamin D2 treatment.
METHODS
Ninety female Sprague-Dawley rats of the
Holtzman farm, with a mean initial body weight
of 100 gm. (range: 96—105 gm.), were subdivided
into 9 equal groups and treated as indicated in
Table I.
Vitamin D2 (Frosst) was administered by stom-
ach tube, in doses of 0.2 mg., 1 mg., or 5 mg., in
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0.5 ml. of Mazola oil, once daily during the first
4 days.
Monobasic sodium phosphate (NaH2PO4) and
calcium acetate were given throughout the experi-
ment in doses of 1 mM in 2 ml. of water, twice
daily, by stomach tube.
On the 4th day, which was the critical time of
vitamin D2 overdosage, the hair was removed by
plucking over the calvarium. Two injections of
FeCl3 were given in an area of shaved skin on the
back, one consisting of 0.1 mg. intracutaneously
and the other of 1 mg. subcutaneously, each in 0.2
ml. of water.
Autopsy was performed after 10 days of treat-
ment. The mean grades of cutaneous calcinosis
listed in the table are based on examination of the
skin 4 days after plucking and at autopsy. The
severity of the lesions was assessed in terms of an
arbitrary scale of 0 to 3 (0 = no lesion, 1 = barely
detectable lesion, 2 = moderate lesion, 3 = most
severe lesion); the mean grades at autopsy are
listed (with standard errors) in the table.
For the purpose of histologic studies, specimens
of the skin, heart, aorta, and kidney were fixed in
alcohol-formol, for the subsequent demonstration
of calcium (von Kóssa and eelestin blue technies)
or iron (Prussian blue technic), and in picric-acid-
saturated Susa solution for staining with tbe PAS
technic.
RESULTS
Readings of cutaneous calcinosis made 4 days
after trauma were almost the same as the final
readings (given in Table I), except in Group S.
In this group, which received 1 mg. injections of
vitamin D2 and Ca-acetate, the lesion developed
more slowly, but at the time of the final reading,
was more severe than in other groups receiving
comparable amounts of vitamin D2.
Group 3, which received 5 mg. of vitamin D2
daily during the first 4 days, showed particularly
severe cutaneous caleinosis, which, unlike in other
groups, was not confined to the plucked area or
the injection site of FeC13.
Intense ealcinosis was seen in Group 5 where a
smaller dose of vitamin D2 (1 mg.) was given in
combination with NaH2PO4 . Most of the animals
in this group showed marked calcification of the
tongue.
The highest mortality occurred among the rats
treated with the highest doses of vitamin D2 (5
mg.) and calcium or phosphate. All rats in Group
6 died on the 4th or 5th day of treatment with
vitamin D2 + Na}IaPO4. In Group 9, where they
received the highest doses of vitamin D2 + Ca-
acetate, the rats died from the 4th to the 7th day
of the experiment. Because of this early mortality,
the extremely severe skin lesions in these two
groups could not be compared with the others at
the time of the final readings; hence, they are not
listed in the table.
Cardiovascular and renal calcification ran
roughly parallel to the cutaneous calcification.
Histologic examination of the skin specimens
revealed that, in these vitamin-D2-treated rats,
Systemic Treatment
TABLE I
Role of Vitamin D2 and electrolytes in production of cutaneous calcinosis
Lesions (scale 0—3) in skin treated by:
Epilation
Group
1
2
3
4
5
6
7
8
9
vitamin n5
(ng.)
0.2
1.0
5.0
0.2
1.0
5.0
0.2
1.0
5.0
FeCis
(0.1 mg. i.e.)
Mortality(%)
Electrolyte
None
None
None
NaH2PO4
NaH2PO4
NaH2PO4
Ca-acetate
Ca-acetate
Ca-acetate
FeCls
(I mg. s.c.)
0
0.3 0.21
3.0 0
0
2.3 0.40
0
3.0 0
0.3 0.21
2.3 0.15
3.0 0
1.2 0.22
2.7 0.21
0.4 0.27
3.0 0
0.3 0.17
2.9 0.10
3.0 0
1.0 0.17
2.7 0.30
0.3 0.21
3.0 0
0
0
20
0
0
100
0
60
100
All animals were traumatized locally by plucking the hair over the calvarium on the 4th day. Vita-
min D2 was given daily for 4 days. Ca-acetate and NaH2PO4 were given throughout the experiment.
FeCl3 injections were given once on the 4th day. The readings of cutaneous caleinosis represent the
condition on the 11th day.
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the microscopically detectable lesions exhibited
structural characteristics essentially similar to
those previonsly described as typical of the
cutaneous calcinosis induced by DHT and
epilation (9); hence, we need not discuss them
here in detail.
In essence, initially there is calcium deposition
in the form of small granules along the course of
the collagen fibers, with considerable swelling of
the latter, edema, a mild inflammatory response,
and eventually, massive calcification in the derma,
the hair follicles, and the subcutis. In later stages,
the calcium deposits tend to be eliminated by
exulccration. Eventually, the lesion heals, vir-
tually without leaving a trace, although for some
time marked sclerosis or atrophy of the dcrma
with disappearance of hair follicles and cutaneous
glands may persist, even after the calcium
deposits have disappeared (Figs. 1 & 2). The
lingual lesions arc quite similar (Figs. 3 & 4).
In order to determine whether DIIT and
vitamin D2 have any noteworthy local effects
themselves, additional experiments were per-
formed in which these compounds were injected
subcutaneously (in oil or water), in doses up to
0.1 mg. Although these amounts are far in excess
of that which could conceivably reach the inj cc-
tion area after oral treatment with such com-
pounds, local calcium deposition was never
observed. Similarly, without systemic sensitiza-
tion by DHT or vitamin D2, massive topical
calcinosis could not be obtained in rats given
FeC13 in doses of 0.1 mg. intracutaneously or oven
1 mg. subcutaneously, that is, in the amounts
that proved so effective following oral vitamin D2
sensitization. It is noteworthy, however, that
FeC13 so applied results not only in the ap-
pearance of macrophages, which phagocytosc iron
granules, but also causes a marked, but highly
selective, iron impregnation of all the collagen
fibrils in the region of the injection. On slides
stained with hematoxylin—cosin or the PAS pro-
cedure, this change is associated with diffuse
basophilia of the injection-region. The exact
position of the iron deposits is very clearly visible
in preparations stained with the Prussian blue
technic (Figs. 5 & 6).
DISCUSSION
The results of our experiments clearly indicate
that cutaneous calcinosis can be obtained at the
site of mechanical (epilation) or chemical (FeC13)
trauma, in animals sensitized by oral vitamin D2
treatment. Both NaH2PO4 and Ca-acetate
augment this sensitizing action of vitamin D2.
This synergism between the vitamin and the
electrolytes manifests itself, not only as regards
the induction of cutaneous calcinosis, but also,
and roughly to the same extent, as regards
the production of cardiovascular calcification,
ncphrocalcinosis, and mortality.
The extraordinary effectiveness of FeCl3 as a
topical elicitor of calcification is worthy of special
comment. Under the conditions of the present
experimental series, a single intracutaneous
injection of as little as 0.1 mg. sufficed to elicit
pronounced calcification of the skin, following
sensitization with vitamin D2. In preliminary
experiments (not reported here in detail), we were
able to show that even one injection of 10 Mg. is
effective in this respect if the animals are opti-
mally sensitized with, for example, 50 pg. per day
of DHT, which is more efficacious than vitamin
D2 in this regard.
The mechanism through which FcCl3 exerts
this action is still not clearly understood. The
histologic demonstration of a fcrruginous in-
crustation of the collagen fibers in the injected
area suggests that iron may impart a particular
calcium affinity to these connective-tissue ele-
ments, which are nsually the first to take up cal-
cium. Iron notoriously tends to accompany cal-
cium in various forms of soft-tissue calcification.
The well-known "Gamna corpuscles" that may
occur in the spleen, liver, or ovaries represent a
prototype of this kind of "sidcrocalcinosis" (11).
In general, pathologists have considered the
deposition of iron in foci of soft-tissue calcifica-
tion as a secondary phenomenon due to absorp-
tion of blood-borne iron on the calcium pre-
cipitate; however, in our case, there can be no
doubt that the iron we injected was the primary
factor and produced favorable conditions for the
secondary deposition of calcium.
It remains to be seen to what extent this action
of FeC13 is specific; but it is clear from onr experi-
ments that it is more effective in attracting
calcium than is the trauma of epilation. Extensive
preliminary experiments testing many types of
local injury (trauma by pinching with a hemostat,
intra- and subcutaneous injection of various
drugs), indicated that none surpassed the efficacy
of FeC13 in this respect. The inflammation
(granuloma formation, exudation) and local
FIG. 1. Typical cutaneous calcification in a rat treated with vitamin D2 + NaII2PO4 (Group 4). There
is a small calicifled plaque in the derma and a larger one in the subcutis underneath the cutaneous mus-
cle. Note that with the celestin blue technic, the outer margin of the calcified region and beginning
calcium deposition on collagen fibers stain selectively (Celestin blue X 68).
FIG. 2. Higher magnification of a region in the slide shown in Figure 1. Here, the selective staining
of apparently recently calcified regions is even more evident (Celestin blue X 368).
FIG. 3. Calcification in the tongue in a rat of Group 5. With the von Kdssa technic, the calcified
regions are stained throughout. Here, fine histologic studies are difficult, because the heavily calcified
parts stain solid black and show no structural details; they break up into fragmented, smudgy structures
owing to excessive silver impregnation (von Kdssa >< 90).
FIG. 4. The region shown in Figure 3 is here stained with celestin blue. Note again the selective
calcification of the margin of the calcified regions and the much greater clarity of structural detail that
is due to the fact that, unlike with the von Kdssa technic, staining is here strictly limited to the
affected structural elements and there is no diffuse "bleeding" of the dye into the surroundings (Celestin
blue X 90).
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FIG. 5. Iron impregnation of the collagen fibers and some histiocytes in the FeC11-injected connec-
tive tissue of a rat not sensitized with vitamin P2 (Prussian blue X 368).
FIG. 6. In a more peripheral region of the FcC11 injection-site shown in Figure 5, iron impregnation
is limited to the cytoplasm of the fibroblasts and to some phagocytes, while the collagen fibers remain
unaffected (Prussian blue X 368).
calcification produced by an agent were in no way
correlated, in rats treatcd with vitamin P1 or
PUT. Indeed, very strong inflammatory irritants
(e.g., croton oil) or agents conducive to topical
necrosis (intense heat or cold) were singularly
ineffective in precipitating local calcification.
In our experiments—as in the clinical calcifying
scleroderma—the mineral depositions are ac-
companied by sclerosis; sclerotic changes are also
frequent accompaniments of iron deposition
without calcification (for example, the hepatic
and pancreatic sclerosis in hemochromatosis).
Hence, further studies along these lines would
appear to hold promise.
Finally, it should be pointed out that although
vitamin P1 is much more effective than PUT in
the cure of rickets, the reverse is true of the
cutaneous calcinosis-producing action of these
two compounds. Exact comparative determina-
tions of activity have not yet been carried out,
but it may be said that, in our earlier studies with
DHT, we obtained sensitization to cutaneous
calcinosis with approximately one-tenth of the
minimum dose of vitamin P2 that proved ef-
fective in the experiments reported here.
SUMMARY
Experiments on rats indicate that, following
oral administration of vitamin D1, epilation of a
skin region suffices to produce topical cutaneous
calcinosis with sclerosis. Intra- or subcutaneous
injection of dilute ferric chloride proved even
much more effective in this respect.
Oral administration of NaH1PO4 or calcium
acetate greatly augmented the ability of vitamin
P1 to sensitize for the induction of cutaneous
calcinosis under these experimental conditions.
The same electrolytes also augmented the
ability of vitamin P1 overdosage to produce
calcium depositions in the cardiovascular system
and the kidney.
In rats not sensitized by vitamin P1 supple-
ments, similar topical treatment of the skin with
FcC13 induced a histochemically demonstrable,
rather selective iron deposition in the regional
macrophagcs and collagen fibers. This was not
associated with any excessive calcium deposition.
Injection of vitamin P1 or PUT into the skin
causes no local calcinosis; hence, the effect of
these compounds appears to be indirect and not
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merely dependent upon their concentration in a
given tissue area.
It remains to be seen whether the experimental
cutaneous lesions induced in this manner are
fundamentally related to the clinical syndrome of
calcifying seleroderma ("selCrodermie ealcaire");
bnt in any event, they furnish a reliable and
simple laboratory model for the study of those
factors that influence cutaneous calcification.
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